US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

CNS/Neurology: market research reports

RSS Feeds

CNS/Neurology market research reports and industry analysis

1  2    4    6  7  8  9  10  
Bipolar Disorder Partnering 2009-2014
2/1/2014 | published by: Current Partnering
... of bipolar disorder partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors bipolar disorder technology. These deals tend to ...  |  read more...
$995.00
Motor Neurone Disease Partnering 2009-2014
2/1/2014 | published by: Current Partnering
... report provides an analysis of motor neurone disease partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors migraine technology. ...  |  read more...
$995.00
Global Depression Drugs Market 2014-2018
1/17/2014 | published by: Infiniti Research Limited - TechNavio
... growth is the increase in the number of patients suffering from depression. The Global Depression Drugs market has also been witnessing the growing awareness of depression drugs. However, the generic erosion of key blockbuster drugs ...  |  read more...
$2,500.00
Global Amyotrophic Lateral Sclerosis Market 2014-2018
1/17/2014 | published by: Infiniti Research Limited - TechNavio
... to this market growth is the increasing global aging population. The Global Amyotrophic Lateral Sclerosis Drugs Market has also been witnessing the increasing awareness of ALS drugs. However, the patent expiry of Rilutek could pose ...  |  read more...
$2,000.00
Cognitive Assessment and Training Market [Dementia Screening; Clinical Trials, Classroom Learning, Brain Training, Cognitive Abilities Test (CogAT, CAT), Concussion Management, Academic Research] Worldwide Market Forecasts and Analysis (2013-2018)
1/16/2014 | published by: MarketsandMarkets
... training is defined as solution that is able to monitor, assess, train, or enhance cognitive functions. These solutions are applied for several uses such as in dementia screening, clinical trials, driver’s safety, rehabilitation, academic research, ...  |  read more...
$4,650.00
Orphan Drugs for CNS Diseases: R&D and Market 2014-2024
1/10/2014 | published by: Visiongain
... report gives you predictions for those therapies. Stay ahead. There you explore sales results, technologies, R&D trends, opportunities, and revenue forecasts. So see what's possible for treating unusual neurological conditions. Avoid missing out. You gain ...  |  read more...
$2,788.00
Neural Control Trends
1/1/2014 | published by: Global Industry Analysts
... the prospective application areas. In addition, the report also expounds the drawbacks of cyborg insects. Neural control, also known as neural interaction or neural interfacing, is touted to emerge as a revolutionary technology and a ...  |  read more...
$950.00
Malignant Glioma - Pipeline Review, H2 2013
12/31/2013 | published by: Global Markets Direct
... for Malignant Glioma, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Malignant Glioma. Malignant Glioma - Pipeline Review, Half Year ...  |  read more...
$2,000.00
Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H2 2013
12/31/2013 | published by: Global Markets Direct
... This report provides information on the therapeutic development for Cognitive Impairment Associated With Schizophrenia (CIAS), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the ...  |  read more...
$2,000.00
High-Grade Glioma - Pipeline Review, H2 2013
12/31/2013 | published by: Global Markets Direct
... for High-Grade Glioma, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for High-Grade Glioma. High-Grade Glioma - Pipeline Review, Half Year ...  |  read more...
$2,000.00
Progressive Supranuclear Palsy - Pipeline Review, H2 2013
12/31/2013 | published by: Global Markets Direct
... therapeutic development for Progressive Supranuclear Palsy, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Progressive Supranuclear Palsy. Progressive Supranuclear Palsy ...  |  read more...
$2,000.00
Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H2 2013
12/31/2013 | published by: Global Markets Direct
... on the therapeutic development for Recurrent Glioblastoma Multiforme (GBM), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Recurrent Glioblastoma Multiforme ...  |  read more...
$2,000.00
General Anxiety Disorder - Pipeline Review, H2 2013
12/31/2013 | published by: Global Markets Direct
... therapeutic development for General Anxiety Disorder, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for General Anxiety Disorder. General Anxiety Disorder ...  |  read more...
$2,000.00
Tinnitus - Pipeline Review, H2 2013
12/31/2013 | published by: Global Markets Direct
... complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Tinnitus. Tinnitus - Pipeline Review, Half Year is built using data and ...  |  read more...
$2,000.00
Medulloblastoma Global Clinical Trials Review, H2, 2013
12/30/2013 | published by: GlobalData
... relating to the clinical trials on Medulloblastoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage ...  |  read more...
$2,500.00
Central Nervous System Partnering Terms and Agreements
12/1/2013 | published by: Current Partnering
... provides a detailed understanding and analysis of how and why companies enter central nervous system partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option ...  |  read more...
$2,995.00
Psychiatry Partnering Terms and Agreements
12/1/2013 | published by: Current Partnering
... and analysis of how and why companies enter psychiatry partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors psychiatry ...  |  read more...
$2,995.00
Glioblastoma Multiforme (GBM) Global Clinical Trials Review, H2, 2013
11/30/2013 | published by: GlobalData
... report provides elemental information and data relating to the clinical trials on Glioblastoma Multiforme (GBM). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across ...  |  read more...
$2,500.00
Astrocytoma Global Clinical Trials Review, H2, 2013
11/30/2013 | published by: GlobalData
... relating to the clinical trials on Astrocytoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage ...  |  read more...
$2,500.00
Conference Documentation: Clinical Trials in CNS
11/18/2013 | published by: SMI Publishing, Ltd
... to London. With an ever increasing average life expectancy, neurodegenerative diseases are increasingly becoming more prevalent in society. With this comes a need for new and improved therapies for treating these neurodegenerative conditions. From Alzheimer's ...  |  read more...
$788.78
EpiCast Report: Schizophrenia - Epidemiology Forecast to 2022
11/15/2013 | published by: GlobalData
... motivation. Schizophrenia affects men and women equally, and usually starts in young adulthood (between ages 16 and 30 years). Due to the chronic nature of the condition, schizophrenia requires lifelong treatment. Although treatment helps in ...  |  read more...
$3,995.00
EpiCast Report: Trigeminal Neuralgia - Epidemiology Forecast to 2022
11/15/2013 | published by: GlobalData
... with men and most commonly affects people ages 50 years and older. Globally the diagnosed incidence of trigeminal neuralgia varies between 4.3 cases per 100,000 person-years in Rochester, Minnesota, US, and approximately 28.9 cases per ...  |  read more...
$3,995.00
Clinical Development and Trial Operations: Protocol Design and Cost Per Patient Benchmarks
11/1/2013 | published by: Cutting Edge Information
... in this benchmarking study. The report is designed to provide clinical development executives the decision making tools necessary to minimize these challenges and arrive at successful clinical endpoints. The data include key performance indicators, such ...  |  read more...
$7,695.00
Brain Signal Analysis Software Market Outlook to 2017
11/1/2013 | published by: RNCOS
... advanced processing and analysis of the raw EEG data that is acquired using EEG machines on patients. As per our report, “Brain Signal Analysis Software Market Outlook to 2017”, the market for brain signal analysis ...  |  read more...
$1,300.00
Japanese Marktet For Neurovascular Devices
11/1/2013 | published by: iData Research, Inc.
... stents, neurovascular catheters, neurovascular guidewires, deep brain stimulators, spinal cord stimulators, sacral nerve stimulators, intrathecal pumps, frame-based stereotactic systems, frameless stereotactic systems and aneurysm clips. The growth in this market will be driven by the ...  |  read more...
$6,995.00
1  2    4    6  7  8  9  10  
 
Our Clients